BHDPC Is a Novel Neuroprotectant That Provides Anti-neuroinflammatory and Neuroprotective Effects by Inactivating NF-κB and Activating PKA/CREB
Microglia-mediated neuroinflammatory responses are inevitable and important pathological processes in several kinds of disorder of the central nervous system (CNS). Therefore, alleviating activated microglia-induced inflammatory process might be a valuable therapeutic approach to neuroinflammation-r...
Main Authors: | Chuwen Li, Tongkai Chen, Hefeng Zhou, Yu Feng, Maggie P. M. Hoi, Dan Ma, Chao Zhao, Ying Zheng, Simon M. Y. Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2018.00614/full |
Similar Items
-
Effects of CREB1 gene silencing on cognitive dysfunction by mediating PKA-CREB signaling pathway in mice with vascular dementia
by: Xin-Rui Han, et al.
Published: (2018-05-01) -
cAMP Signaling in Cancer: A PKA-CREB and EPAC-Centric Approach
by: Muhammad Bilal Ahmed, et al.
Published: (2022-06-01) -
The COVID-19 Cell Signalling Problem: Spike, RAGE, PKC, p38, NFκB & IL-6 Hyper-Expression and the Human Ezrin Peptide, VIP, PKA-CREB Solution
by: Rupert Donald Holms
Published: (2022-03-01) -
Liraglutide exhibits anti-inflammatory activity through the activation of the PKA/CREB pathway
by: Li Wang, et al.
Published: (2019-10-01) -
Suppression of cAMP/PKA/CREB signaling ameliorates retinal injury in diabetic retinopathy
by: Xiao‐Ling Fang, et al.
Published: (2023-09-01)